Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6.9 USD | -0.58% | -1.29% | +113.62% |
Apr. 25 | Benitec Biopharma Inc. announced that it has received $40.000019 million in funding from a group of investors | CI |
Apr. 18 | Sector Update: Health Care Stocks Mixed in Late Afternoon Trading | MT |
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 27.43M 17.92M |
---|---|---|---|---|---|
Net income 2024 * | - | Net income 2025 * | - | EV / Sales 2024 * | - |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-2.8
x | P/E ratio 2025 * |
-3.88
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 97.88% |
1 day | -0.58% | ||
1 week | -1.29% | ||
Current month | +31.43% | ||
1 month | +34.50% | ||
3 months | +124.76% | ||
6 months | +101.97% | ||
Current year | +113.62% |
Managers | Title | Age | Since |
---|---|---|---|
Jerel Banks
CEO | Chief Executive Officer | 49 | 16-09-30 |
Peter Roelvink
CTO | Chief Tech/Sci/R&D Officer | - | 15-02-28 |
Megan Boston
CMP | Compliance Officer | 52 | 16-07-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
J. Buchi
BRD | Director/Board Member | 69 | 13-03-31 |
Edward Smith
BRD | Director/Board Member | 53 | 20-04-13 |
Peter Francis
BRD | Director/Board Member | 68 | 06-01-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 6.9 | -0.58% | 19,769 |
24-04-25 | 6.94 | +3.27% | 28,704 |
24-04-24 | 6.72 | -2.04% | 66,511 |
24-04-23 | 6.86 | +2.08% | 26,465 |
24-04-22 | 6.72 | -3.86% | 129,458 |
Delayed Quote Nasdaq, April 26, 2024 at 04:30 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+113.62% | 17.89M | |
+1.51% | 42.75B | |
+49.22% | 41.61B | |
+8.57% | 41.34B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
+6.35% | 11B |
- Stock Market
- Equities
- BNTC Stock